Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05526248
Title A Study Called ARAMON to Learn to What Extent Does Study Treatment With Darolutamide Affects Testosterone Levels in Men With Prostate Cancer That Had Not Been Treated With Hormonal Therapy Compared to Treatment With Enzalutamide (ARAMON)
Acronym ARAMON
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Bayer
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.